Oculis Holding AG (OCS) Goodwill & Intangibles (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Goodwill & Intangibles came in at $17.0 million in Q1 2026, up 14.81% year-on-year from $14.8 million in Q1 2025, and up 2.06% quarter-over-quarter from $16.6 million in Q4 2025.

Oculis Holding AG (OCS) Goodwill & Intangibles (2021 - 2026) Analysis & Trends

Oculis Holding AG's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $17.0 million for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles rose 14.81% year-over-year to $17.0 million in Q1 2026; TTM through Mar 2026 was $17.0 million, a 14.81% increase from a year earlier, with the FY2025 full-year figure at $16.0 million, up 6.11% from the prior year.
  • Goodwill & Intangibles improved to $17.0 million in Q1 2026 per OCS's latest filing, from $16.6 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $17.0 million in Q1 2026 and bottomed at $12.7 million in Q4 2022.
  • The 5-year median for Goodwill & Intangibles is $14.1 million (2024), against an average of $14.7 million.
  • Across the five-year window, Goodwill & Intangibles jumped 33.92% in 2022 and dropped 0.57% in 2024, its largest moves.
  • Year by year, Goodwill & Intangibles stood at $12.7 million in 2022, then gained by 8.61% to $13.8 million in 2023, then advanced by 10.27% to $15.2 million in 2024, then increased by 9.61% to $16.6 million in 2025, then gained by 2.06% to $17.0 million in 2026.
  • Per Business Quant, the three latest OCS Goodwill & Intangibles figures stand at $17.0 million (Q1 2026), $16.6 million (Q4 2025), and $16.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.97 Mn
Dec 31, 2025 16.63 Mn
Sep 30, 2025 16.62 Mn
Jun 30, 2025 16.06 Mn
Mar 31, 2025 14.78 Mn
Dec 31, 2024 15.17 Mn
Sep 30, 2024 14.09 Mn
Jun 30, 2024 13.50 Mn
Mar 31, 2024 13.98 Mn
Dec 31, 2023 13.76 Mn
Sep 30, 2023 13.82 Mn
Jun 30, 2023 13.58 Mn
Dec 31, 2022 12.67 Mn
Dec 31, 2021 9.46 Mn